Pulmonary Denervation System Market

Future Market Insights

Pulmonary Denervation System Market

Key Insight

The global pulmonary denervation system market is projected to grow from USD 157.6 million in 2025 to USD 1,184.9 million by 2035, at a CAGR of 22.3%. By technology, radiofrequency denervation systems will lead with a 46.8% share, while by application, pulmonary hypertension will account for the largest share at 44.1% in 2025.

December 17, 2025

Anurag Sharma

250 Pages

Cite this Report

Pulmonary Denervation System Market

https://www.futuremarketinsights.com/reports/pulmonary-denervation-system-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Ablative Solutions
Biosense Webster (J&J)
Boston Scientific
Cordis Corporation
Galvanize Therapeutics
Medtronic plc
NXT Biomedical / Verve Medical
ReCor Medical
TherOx / ZOLL

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Pulmonary Denervation System Market

Key Players

Similar Industry Reports